ResMed

35 years ago, we made a promise to help people worldwide sleep, breathe and live better. Today, we continue to live up to that promise by developing digital health products and cloud-connected solutions that empower people to live happier, healthier, and higher quality lives from the comfort of their home. Thank you to the 10,000 ResMedians working worldwide to help impact the lives of people with sleep apnea, COPD, and other respiratory diseases and sleep disorders. And our deepest gratitude to those who've trusted us to improve their health and quality of life. Here's to the next 35 years! #ResMed35

This past week, we were excited to catch ResMed Chief Medical Officer, Carlos Nunez at HLTH Europe 2024 on the "Dream come true, or a neuro nightmare? Improving your sleep with digital solutions" panel. During the session, Carlos and the panel participants discussed topics such as the current state of sleep monitoring apps & relaxation tech and shared their thoughts on how technology as a whole can help mend our relationship with sleep. #HLTHEurope #HealthInnovation #HealthcareTransformation #DigitalHealth #HealthTech #CPAP #SleepHealth

"Our findings underscore the urgent need for enhanced clinical care pathways and policy interventions to effectively diagnose and treat insomnia. It is crucial to foster greater awareness of the critical role that sleep plays in overall health," - Adam Benjafield, Vice President, Medical Affairs, ResMed Read more about these important #sleephealth research findings coming out of the recent #SLEEP2024 Conference here from Medscape!

As a healthcare practitioner, researcher and someone who has spent much of my career focused on sleep health and conditions like obstructive sleep apnea (OSA) – a condition where obesity is an important risk factor – I am deeply interested in the use of GLP-1 medications for weight loss and the potential benefits that weight loss can have on sleep conditions. It’s especially top of mind for me as I make my way to the American Diabetes Association’s (ADA) Scientific Sessions later this week, where the full results from the SURMOUNT-OSA trial will be released. Without question, the most effective treatment for OSA has been and remains positive airway pressure (PAP) therapy, which has been proven to reduce the severity of sleep apnea by an average of 86% [1]. With that context, it’s important to note that the SURMOUNT-OSA trial was not designed to directly compare the effectiveness of the dual GLP-1/GIP receptor agonist tirzepatide to PAP therapy. Instead, it was designed to determine if use of tirzepatide for weight loss could reduce the apnea-hypopnea index (AHI) when compared with a placebo. By including patients using PAP therapy, the gold standard in OSA treatment, the trial provided information on combination use from a safety perspective [2]. It’s important to remember that weight loss alone may not be sufficient to eliminate OSA. Obesity is not the only risk factor for OSA, and we’ve seen that in >35% of cases where patients lose up to 50% of their body weight via interventions like bariatric surgery, clinically relevant sleep apnea remained present [3]. While we welcome any new advancements that get individuals more engaged in maintaining a healthy lifestyle, it’s important to continue to expand what we know about sleep health and how best to treat conditions like OSA. As clinicians, it’s incumbent upon us to help patients know and understand their risks for conditions like OSA, which can lower quality of life, increase the risk of many serious health conditions, and may even lead to death [4]. We must take this opportunity to raise awareness of the importance of sleep health and ensure that people at risk for sleep health challenges get screened, diagnosed and treated with the treatments that have the highest likelihood of reducing their risk of health complications. I’m looking forward to learning about the science that will be presented and the conversations I’ll have with colleagues at ADA's annual conference. There is so much more for us to talk about now that sleep health is getting more attention. There are 1 billion people with sleep apnea, and more than 80% are undiagnosed and untreated [5]. All of them deserve the chance to live their best, healthiest lives. *sources below in the comments*

What if unlocking the superpowers of restful sleep could help men live healthier, higher-quality lives?   This #InternationalMensHealthWeek, conquer your tiredness and start your journey to good sleep. Take a free sleep assessment today. https://lnkd.in/eC25VP92 #SleepPowers

We're very excited to have wrapped up some incredible few days this past week at #SLEEP2024 in Houston! From presenting groundbreaking research, to engaging with fellow experts in sleep medicine, ResMed has been at the forefront of advancing healthcare innovation. We’re grateful for the opportunity to share our insights and connect with the community. A big thank you to the American Academy of Sleep Medicine for bringing together the SLEEP innovation community. #resmed #sleephealth #healthinnovation

It’s the last day at #SLEEP2024 and we’re excited to be presenting more insights today. If attending, be sure to stop by for the latest research in sleep health!

The host of critical research presented by influential and accomplished experts at ATS continues to show the effectiveness and importance of PAP in treating sleep disordered breathing and limiting their impact on adverse health effects.    Thank you to the ResMed medical affairs team and our esteemed research partners for their work in presenting 26 new studies. The increasing prevalence of cardiovascular conditions, obesity, and an aging population in the United States demonstrates why increasing awareness of sleep health and conducting research into how best to improve sleep quality and overall health outcomes is so critical today. I was also thrilled to speak in two sessions focused on innovation and digital health solutions. Read on for my perspective from this year's American Thoracic Society International Conference (ATS). #ATS2024 #PulmonaryHealth #SleepDisorders #ResMed #HealthcareInnovation #PatientCare #MedicalResearch

Kicking off another exciting day at #SLEEP2024 and our team is back with more valuable insights. Check out our research agenda for the day and be sure to stop by! #sleephealth

🌈 June marks #PrideMonth, a time to recognize and honor the influence of the LGBTIQA+ community. ResMed is part of the celebration of the right for everyone to live authentically, without discrimination. We are committed to fostering belonging in our day-to-day activities and strive to ensure that everyone feels heard, valued, and accepted.   In honor of the month, we turned to leaders from our LGBTIQA+ employee resource group, ResPect, for their reflections. They shared insights on why ResPect is vital, how we can further LGBTIQA+ empowerment and allyship, and what makes them most proud of their community at ResMed.  Join us in celebrating Pride Month and reaffirming our commitment to inclusivity, diversity, and equal rights for all. 🏳️🌈